800
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Polymorphisms of genes related to metotrexate response and toxicity in high-grade osteosarcoma

&

References

  • Hattinger CM, Tavanti E, Fanelli M, et al. Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma. Expert Opin Drug Metab Toxicol. 2016. Forthcoming. DOI:10.1080/17425255.2017.1246532
  • Hattinger CM, Biason P, Iacoboni E, et al. Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma. Oncotarget. 2016. Epub 2016 Aug 22. [Epub ahead of print]. DOI:10.18632/oncotarget.11486
  • Hegyi M, Arany A, Semsei AF, et al. Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma. Oncotarget. 2016. Epub 2016 Aug 23. [Epub ahead of print]. DOI:10.18632/oncotarget.11543
  • Kimchi-Sarfaty C, Gribar JJ, Gottesman MM. Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system. Mol Pharmacol. 2002;62:1–6. Epub 2002 Jun 18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.